223 related articles for article (PubMed ID: 37357610)
21. CXCR4 expression varies significantly among different subtypes of glioblastoma multiforme (GBM) and its low expression or hypermethylation might predict favorable overall survival.
Ma X; Shang F; Zhu W; Lin Q
Expert Rev Neurother; 2017 Sep; 17(9):941-946. PubMed ID: 28685624
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic pathways and glioblastoma treatment: insights from signaling cascades.
Allen BK; Stathias V; Maloof ME; Vidovic D; Winterbottom EF; Capobianco AJ; Clarke J; Schurer S; Robbins DJ; Ayad NG
J Cell Biochem; 2015 Mar; 116(3):351-63. PubMed ID: 25290986
[TBL] [Abstract][Full Text] [Related]
23. Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma.
Ashizawa T; Miyata H; Iizuka A; Komiyama M; Oshita C; Kume A; Nogami M; Yagoto M; Ito I; Oishi T; Watanabe R; Mitsuya K; Matsuno K; Furuya T; Okawara T; Otsuka M; Ogo N; Asai A; Nakasu Y; Yamaguchi K; Akiyama Y
Int J Oncol; 2013 Jul; 43(1):219-27. PubMed ID: 23612755
[TBL] [Abstract][Full Text] [Related]
24. Comparison of glioblastoma (GBM) molecular classification methods.
Lee E; Yong RL; Paddison P; Zhu J
Semin Cancer Biol; 2018 Dec; 53():201-211. PubMed ID: 30031763
[TBL] [Abstract][Full Text] [Related]
25. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3.
Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J
Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931
[TBL] [Abstract][Full Text] [Related]
26. Bioinformatic analyses reveal a distinct Notch activation induced by STAT3 phosphorylation in the mesenchymal subtype of glioblastoma.
Cheng W; Zhang C; Ren X; Jiang Y; Han S; Liu Y; Cai J; Li M; Wang K; Liu Y; Hu H; Li Q; Yang P; Bao Z; Wu A
J Neurosurg; 2017 Jan; 126(1):249-259. PubMed ID: 26967788
[TBL] [Abstract][Full Text] [Related]
27. Genomic estimates of aneuploid content in glioblastoma multiforme and improved classification.
Li B; Senbabaoglu Y; Peng W; Yang ML; Xu J; Li JZ
Clin Cancer Res; 2012 Oct; 18(20):5595-605. PubMed ID: 22912392
[TBL] [Abstract][Full Text] [Related]
28. COXIBs and 2,5-dimethylcelecoxib counteract the hyperactivated Wnt/β-catenin pathway and COX-2/PGE2/EP4 signaling in glioblastoma cells.
Majchrzak-Celińska A; Misiorek JO; Kruhlenia N; Przybyl L; Kleszcz R; Rolle K; Krajka-Kuźniak V
BMC Cancer; 2021 May; 21(1):493. PubMed ID: 33941107
[TBL] [Abstract][Full Text] [Related]
29. Juglone in Combination with Temozolomide Shows a Promising Epigenetic Therapeutic Effect on the Glioblastoma Cell Line.
Barciszewska AM; Belter A; Gawrońska I; Giel-Pietraszuk M; Naskręt-Barciszewska MZ
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108161
[TBL] [Abstract][Full Text] [Related]
30. PRMT5-PTEN molecular pathway regulates senescence and self-renewal of primary glioblastoma neurosphere cells.
Banasavadi-Siddegowda YK; Russell L; Frair E; Karkhanis VA; Relation T; Yoo JY; Zhang J; Sif S; Imitola J; Baiocchi R; Kaur B
Oncogene; 2017 Jan; 36(2):263-274. PubMed ID: 27292259
[TBL] [Abstract][Full Text] [Related]
31. iGlioSub: an integrative transcriptomic and epigenomic classifier for glioblastoma molecular subtypes.
Ensenyat-Mendez M; Íñiguez-Muñoz S; Sesé B; Marzese DM
BioData Min; 2021 Aug; 14(1):42. PubMed ID: 34425860
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitors.
Singh MM; Manton CA; Bhat KP; Tsai WW; Aldape K; Barton MC; Chandra J
Neuro Oncol; 2011 Aug; 13(8):894-903. PubMed ID: 21653597
[TBL] [Abstract][Full Text] [Related]
33. Capturing the latent space of an Autoencoder for multi-omics integration and cancer subtyping.
Madhumita ; Paul S
Comput Biol Med; 2022 Sep; 148():105832. PubMed ID: 35834966
[TBL] [Abstract][Full Text] [Related]
34. Molecular heterogeneity in a patient-derived glioblastoma xenoline is regulated by different cancer stem cell populations.
Garner JM; Ellison DW; Finkelstein D; Ganguly D; Du Z; Sims M; Yang CH; Interiano RB; Davidoff AM; Pfeffer LM
PLoS One; 2015; 10(5):e0125838. PubMed ID: 25955030
[TBL] [Abstract][Full Text] [Related]
35. Discovering gene-environment interactions in glioblastoma through a comprehensive data integration bioinformatics method.
Kunkle B; Yoo C; Roy D
Neurotoxicology; 2013 Mar; 35():1-14. PubMed ID: 23261424
[TBL] [Abstract][Full Text] [Related]
36. Machine learning revealed stemness features and a novel stemness-based classification with appealing implications in discriminating the prognosis, immunotherapy and temozolomide responses of 906 glioblastoma patients.
Wang Z; Wang Y; Yang T; Xing H; Wang Y; Gao L; Guo X; Xing B; Wang Y; Ma W
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33839757
[TBL] [Abstract][Full Text] [Related]
37. MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma.
Donson AM; Addo-Yobo SO; Handler MH; Gore L; Foreman NK
Pediatr Blood Cancer; 2007 Apr; 48(4):403-7. PubMed ID: 16609952
[TBL] [Abstract][Full Text] [Related]
38. Identification of Global DNA Methylation Signatures in Glioblastoma-Derived Cancer Stem Cells.
Lee EJ; Rath P; Liu J; Ryu D; Pei L; Noonepalle SK; Shull AY; Feng Q; Litofsky NS; Miller DC; Anthony DC; Kirk MD; Laterra J; Deng L; Xin HB; Wang X; Choi JH; Shi H
J Genet Genomics; 2015 Jul; 42(7):355-71. PubMed ID: 26233891
[TBL] [Abstract][Full Text] [Related]
39. Overview of Transforming Growth Factor β Superfamily Involvement in Glioblastoma Initiation and Progression.
Nana AW; Yang PM; Lin HY
Asian Pac J Cancer Prev; 2015; 16(16):6813-23. PubMed ID: 26514451
[TBL] [Abstract][Full Text] [Related]
40. A glycolysis-based ten-gene signature correlates with the clinical outcome, molecular subtype and IDH1 mutation in glioblastoma.
Chen C; Shi Y; Li Y; He ZC; Zhou K; Zhang XN; Yang KD; Wu JR; Kung HF; Ping YF; Bian XW
J Genet Genomics; 2017 Nov; 44(11):519-530. PubMed ID: 29169920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
